WebSee Fisker Inc. (FSR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. WebFisker Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: ... The average deviation from the average price over the last 30 days. Historical Volatility is ...
FSR: Fisker Inc - Stock Price, Quote and News - CNBC
WebThe current P/S ratio for Fisker as of April 07, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide . Historical PS ratio values for Fisker (FSR) over the last 10 years. ... Fisker P/S Ratio Historical Data; Date Stock Price TTM Sales per Share Price to Sales Ratio; 2024-04-06: 5.39: ... WebApr 13, 2024 · Fisker Inc. (NYSE:FSR) shares, rose in value on Wednesday, 04/12/23, with the stock price down by -3.56% to the previous day’s close as strong demand from … flowers mountain view
Fisker Inc.’s (NYSE:FSR) Stock Loses -3.56%: A Look At Its Most Probabl…
WebHistorical daily price data is available for up to two years prior to today's date. For more data, Barchart Premier members can download more historical data (going back to Jan. … Web102 rows · Apr 10, 2024 · Fisker Inc. (FSR) NYSE - NYSE Delayed Price. Currency in USD. Follow. 2W 10W 9M. 5.39 +0.03 ... Find the latest Fisker Inc. (FSR) stock discussion in Yahoo Finance's forum. … NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors trend 2W 10W 9M Find out all the key statistics for Fisker Inc. (FSR), including valuation measures, … Fisker Inc. (FSR) NYSE - NYSE Delayed Price. Currency in USD. Follow. Visitors … Holder Shares Date Reported % Out Value; Vanguard Total Stock Market Index … As of 10:24AM EDT. Market open. LOS ANGELES, April 06, 2024--Fisker Inc. … WebView the latest Fisker Inc. (FSR) stock price, news, historical charts, analyst ratings and financial information from WSJ. greenberg oncology